Somewhat Negative News Coverage Somewhat Unlikely to Affect Victory Capital (VCTR) Stock Price

News coverage about Victory Capital (NASDAQ:VCTR) has trended somewhat negative on Saturday, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Victory Capital earned a coverage optimism score of 0.00 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 44.5179898229754 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

VCTR stock opened at $11.92 on Friday. Victory Capital has a 12 month low of $11.03 and a 12 month high of $13.50.

How to Become a New Pot Stock Millionaire

A number of brokerages have recently commented on VCTR. JPMorgan Chase & Co. began coverage on Victory Capital in a report on Monday, March 5th. They set an “overweight” rating and a $14.50 price target for the company. Keefe, Bruyette & Woods began coverage on Victory Capital in a report on Monday, March 5th. They set a “market perform” rating for the company. William Blair began coverage on Victory Capital in a report on Monday, March 5th. They set an “outperform” rating for the company. Bank of America began coverage on Victory Capital in a report on Monday, March 5th. They set a “buy” rating and a $17.00 price target for the company. Finally, Barclays began coverage on Victory Capital in a report on Monday, March 5th. They set an “overweight” rating and a $16.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $15.93.

In other news, Director Lawrence Davanzo bought 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, February 28th. The stock was acquired at an average cost of $12.90 per share, for a total transaction of $258,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO David Craig Brown bought 16,500 shares of the business’s stock in a transaction that occurred on Thursday, February 8th. The stock was purchased at an average price of $12.20 per share, with a total value of $201,300.00. The disclosure for this purchase can be found here. Insiders purchased 385,500 shares of company stock valued at $4,882,400 over the last 90 days.

WARNING: “Somewhat Negative News Coverage Somewhat Unlikely to Affect Victory Capital (VCTR) Stock Price” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.tickerreport.com/banking-finance/3294687/somewhat-negative-news-coverage-somewhat-unlikely-to-affect-victory-capital-vctr-stock-price.html.

Victory Capital Company Profile

Victory Capital Holdings, Inc is an investment management company. The Company’s model features an operating platform that provides centralized distribution, marketing and operations infrastructure to its franchises and solutions platform. Its solutions platform consists of multi-Franchise and customized solutions strategies that are primarily rules-based.

Receive News & Ratings for Victory Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victory Capital and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

TESSCO Technologies  vs. CUI Global  Head to Head Review
TESSCO Technologies vs. CUI Global Head to Head Review
Carlyle Group  Upgraded to “Sell” at BidaskClub
Carlyle Group Upgraded to “Sell” at BidaskClub
Reviewing OSI Systems  & The Competition
Reviewing OSI Systems & The Competition
Diplomat Pharmacy  Receiving Somewhat Favorable News Coverage, Report Shows
Diplomat Pharmacy Receiving Somewhat Favorable News Coverage, Report Shows
Aqua America  Earns “Outperform” Rating from Boenning Scattergood
Aqua America Earns “Outperform” Rating from Boenning Scattergood
Regulus Therapeutics  Set to Announce Earnings on Wednesday
Regulus Therapeutics Set to Announce Earnings on Wednesday


© 2006-2018 Ticker Report. Google+.